{
    "2018-01-09": [
        [
            {
                "time": "",
                "original_text": "医药生物行业: 估值底部出现, 三维度精选标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值底部",
                        "精选标的"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中生制药涨逾2% 瑞信续予优于大市",
                "features": {
                    "keywords": [
                        "中生制药",
                        "涨逾2%",
                        "瑞信",
                        "优于大市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}